Larimar Therapeutics
mad trial patient disease characteristics | Larimar Therapeutics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
29 of 44
Similar slides by Larimar Therapeutics
See diffirences between slides (animation)
Investor Presentation
November 2023
disease characteristics phase cohort | Larimar Therapeutics
Investor Presentation
November 2023
mad trial patient demographics | Larimar Therapeutics
Related slides by other companies
DICE Therapeutics
Investor Presentation
March 2023
phase demographics and disease characteristics dice | DICE Therapeutics
DICE Therapeutics
Results
March 2023
demographics and disease characteristics dice | DICE Therapeutics
Aeglea BioTherapeutics
Investor Presentation
May 2023
peace demographics | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
April 2023
peace demographics | Aeglea BioTherapeutics
Other recent decks by Larimar Therapeutics
See all presentations (3 decks)
Results
November 2022
Investor Presentation
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights